reboxetine has been researched along with naltrindole in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (naltrindole) | Trials (naltrindole) | Recent Studies (post-2010) (naltrindole) |
---|---|---|---|---|---|
626 | 193 | 184 | 801 | 0 | 139 |
Protein | Taxonomy | reboxetine (IC50) | naltrindole (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0007 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frishtick, R; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I; Weizman, R | 1 |
1 other study(ies) available for reboxetine and naltrindole
Article | Year |
---|---|
The antinociceptive properties of reboxetine in acute pain.
Topics: Adrenergic Antagonists; Analgesics; Animals; Antidepressive Agents; Clonidine; Disease Models, Animal; Drug Interactions; Male; Mice; Mice, Inbred ICR; Morphine; Morpholines; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Reboxetine; Receptors, Opioid, mu | 2009 |